Global Blood Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: GBT insiders have only sold shares in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Individual Insiders | 1,520,450 | 2.07% |
| VC/PE Firms | 3,646,690 | 4.97% |
| Hedge Funds | 3,732,502 | 5.09% |
| Institutions | 64,468,219 | 87.9% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 8.1%.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 6,019,431 | US$412.3m | -0.08% | 0.01% | |||
| 4,772,391 | US$326.9m | -9.69% | 0.01% | |||
| 4,478,248 | US$306.7m | -20.1% | 0.17% | |||
| 4,423,544 | US$303.0m | 28% | 0.02% | |||
| 3,732,502 | US$255.6m | 12.6% | 1.49% | |||
| 3,646,690 | US$249.8m | 58.2% | 11.97% | |||
| 3,106,801 | US$212.8m | -2.34% | 0.03% | |||
| 3,081,637 | US$211.1m | -24.7% | 0.02% | |||
| 3,015,054 | US$206.5m | -22.5% | 6.19% | |||
| 2,200,000 | US$150.7m | 64.3% | 28.3% | |||
| 2,044,000 | US$140.0m | 29.7% | 2.37% | |||
| 1,586,974 | US$108.7m | 70.4% | 0.3% | |||
| 1,501,382 | US$102.8m | 0% | 6.81% | |||
| 1,445,566 | US$99.0m | 49.5% | 18.65% | |||
| 1,351,554 | US$92.6m | -31.3% | 0.14% | |||
| 1,095,810 | US$75.1m | 0% | 0.4% | |||
| 1,083,836 | US$74.2m | -0.26% | 0.01% | |||
| 953,396 | US$65.3m | -19.4% | 11.62% | |||
| 951,111 | US$65.1m | 47.9% | 0.14% | |||
| 947,614 | US$64.9m | 0% | 1.07% | |||
| 922,618 | US$63.2m | -16.6% | no data | |||
| 805,861 | US$55.2m | 0% | 0.61% | |||
| 802,390 | US$55.0m | 34.4% | 3.9% | |||
| 800,000 | US$54.8m | -39.6% | 3.85% | |||
| 797,986 | US$54.7m | 40.7% | 0.01% |